HNN3.0
Register
Register
Register

Project cooperationUpdated on 29 December 2025

Z-Anatomy: a Collaborative, Open-Source 3D Atlas of Anatomy

2D/3D graphic designer specializing in human and veterinary anatomy at Z-Anatomy

Montpellier, France

About

Z-Anatomy is developing open-source 3D anatomy atlases (CC-BY-SA 4.0) for human and veterinary education. We’re launching a crowdfunding campaign to:

  • Hire a Unity developer (full- or part-time) to refine our interactive app (performance, UX, educational features).

  • Create new models (e.g., female anatomy, livestock species) using validated scientific data.

  • Sustain long-term growth through community-driven development.

Participatory Model:

  • Shared Funding: Universities, museums, and institutions co-fund model development, gaining priority support and custom requests.

  • Collaborative Review: Contributors (educators, researchers, students) help validate and improve models and tools.

  • Cost-Sharing: Development costs are distributed among partners, reducing individual financial burden.

What We Offer:
Ready-to-use 3D models (human, cat, etc.) for education/research.
Open-source workflows (Blender/Unity) for collaborative development.
Study & revision app with adaptive features (quizzes, phylogenetic comparisons).
Visibility & recognition for partners (credits, early access, co-branding).

What We Need:
💰 Financial contributions (crowdfunding/partnerships) for developer salaries (~€30-50K/year) and model creation.
🔬 Scientific data: CT scans (universities, hospitals, museums) to expand our library.
💻 Technical expertise: Unity/Blender support or training.
🎓 Scientific validation: Academic partnerships to ensure accuracy.

Why Support Us?
🔹 Direct impact: Fund a tangible project with measurable outcomes (new models, features, updates).
🔹 Priority access: Contributors receive dedicated support and influence future developments.
🔹 Transparency & scalability: Open-source core with partner-driven enhancements.

Next Steps:
If your institution (university, museum, foundation) is interested in this participatory model, let’s discuss collaboration terms. We’ll tailor benefits to your needs (e.g., co-branded tools, exclusive early access).

Contact: Gauthier Kervyn | Founder, Z-Anatomy 📧 gauthier.kervyn@z-anatomy.com | 📞 +33 7 66 25 40 75

Topic

  • DESTINATION 1: HORIZON-HLTH-2026-01-STAYHLTH-03: Building public trust and outreach in the life sciences
  • DESTINATION 4: HORIZON-HLTH-2026-01-CARE-01: Public procurement of innovative solutions for improving citizens' access to healthcare through integrated or personalised approaches
  • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
  • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices

Type

  • Consortium/Coordinator seeks Partners

Organisation

Z-Anatomy

Company (SME)

Montpellier, France

Similar opportunities

  • Project cooperation

    Medical education collaboration

    • Consortium/Coordinator seeks Partners
    • Partner seeks Consortium/Coordinator
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-15: Scaling up innovation in cardiovascular health
    • DESTINATION 1: HORIZON-HLTH-2026-01-STAYHLTH-03: Building public trust and outreach in the life sciences
    • DESTINATION 6: HORIZON-HLTH-2026-01-IND-03: Regulatory science to support translational development of patient-centred health technologies
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-05: Pilot actions for follow-on funding: Leveraging EU-funded collaborative research in regenerative medicine
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-11: Understanding of sex and/or gender-specific mechanisms of cardiovascular diseases: determinants, risk factors and pathways
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-09: Multisectoral approach to tackle chronic non-communicable diseases: implementation research maximising collaboration and coordination with sectors and in settings beyond the healthcare system (GACD)

    Luca Takács

    Founder and CEO at LNP Academy

    Budapest, Hungary

  • Project cooperation

    Medere – Digital and Additive Medical Devices for Personalized Care and Remote Monitoring

    • Partner seeks Consortium/Coordinator
    • DESTINATION 4: HORIZON-HLTH-2026-01-CARE-03: Identifying and addressing low-value care in health and care systems
    • DESTINATION 6: HORIZON-HLTH-2026-01-IND-03: Regulatory science to support translational development of patient-centred health technologies
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-05: Pilot actions for follow-on funding: Leveraging EU-funded collaborative research in regenerative medicine
    • DESTINATION 4: HORIZON-HLTH-2026-01-CARE-01: Public procurement of innovative solutions for improving citizens' access to healthcare through integrated or personalised approaches

    Giulia De Pascali

    Operations & Quality Manager at MEDERE S.R.L.

    Roma, Italy

  • Project cooperation

    Expertise in insilico model

    • Partner seeks Consortium/Coordinator
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-15: Scaling up innovation in cardiovascular health
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-03: Advancing research on the prevention, diagnosis, and management of post-infection long-term conditions
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-05: Pilot actions for follow-on funding: Leveraging EU-funded collaborative research in regenerative medicine
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-07: Establishing a European network of Centres of Excellence (CoEs) for Advanced Therapies Medicinal Products (ATMPs)
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-11: Understanding of sex and/or gender-specific mechanisms of cardiovascular diseases: determinants, risk factors and pathways
    • DESTINATION 4: HORIZON-HLTH-2026-01-CARE-01: Public procurement of innovative solutions for improving citizens' access to healthcare through integrated or personalised approaches
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices

    Davide Baroli

    Research scientist at Ricam oeaw

    Linz, Italy